[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
::
Basic and Clinical Biochemistry and Nutrition
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
:: Volume 27, Issue 1 (Bimonthly 2023) ::
Feyz 2023, 27(1): 90-96 Back to browse issues page
Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021
Afshin Ahmadvand , Motahhareh Mansournejad , Zahra Sepehrmanesh
Clinical Research Development Unit Matini /Kargarnejad Hospitals, Kashan University of Medical Sciences, Kashan, I.R. Iran. , z.sepehrmanesh@gmail.com
Abstract:   (552 Views)
Background: Sexual dysfunction is a common complication of methadone maintenance therapy (MMT) and buprenorphine maintenance therapy (BMT). The aim of this study was to evaluate of sexual function in addicted men under treatment with methadone and buprenorphine.
Materials and Methods: In this cross-sectional study, 30 men undergoing methadone maintenance treatment (n=15) and buprenorphine (n=15) were included in the study in Kashan addiction treatment centers. The Golombok-Rust Inventory of Sexual Satisfaction (GRISS) questionnaire was used to collect data. The collected data were analyzed using SPSS version 22 software and using Fisher's exact tests, independent t test and linear regression.
Results: There was no significant difference in the mean total score of sexual performance between the methadone (38.40±13.58) and buprenorphine (38.33±14.56) groups (P=0.733).
Conclusion: The results showed that in both groups, sexual performance was at an unfavorable level, and therefore, it is recommended that future studies focus on providing strategies to improve sexual performance and satisfaction in patients undergoing maintenance treatment with methadone and buprenorphine.
Keywords: Addiction, Sexual dysfunction, Methadone maintenance therapy (MMT), Buprenorphine maintenance therapy (BMT)
Full-Text [PDF 337 kb]   (299 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2022/09/19 | Revised: 2023/07/25 | Accepted: 2023/02/19 | Published: 2023/04/5
References
1. Feng L, Zhang W, Li X. Monitoring of regional drug abuse through wastewater-based epidemiology—A critical review. Sci China Earth Sci 2018; 61(3): 239-55.
2. Aramideh Z, Sahbaeiroy F. Sustained Remission from Drug Addiction among the Attendees of the Meetings of Anonymous Addicts and Rehabilitation Centers in Mashhad, Iran, During 2017. SBRH 2019; 3(2): 378-84.
3. Jamshidi F, Nazari I, Cheraghi M. Risky behaviors of injecting drug users [IDUs) referred to addiction rehabilitation centers in Khuzestan Province in 2014. Online J Health Allied Sci 2017; 16: 5.
4. Rizal MRM, Khan AH, Harun SN, Saleh Z. Gender differences on methadone maintenance treatment outcome among patients with opioid use disorder: A systematic review. J Pharmacy Bioallied Sci 2020; 12(6): 657.
5. Mattick R, Ali R, Lintzeris N. Pharmacotherapies for the treatment of opioid dependence: Efficacy, cost-effectiveness and implementation guidelines: Informa; 1st ed. 2009. 520
6. Jordan CJ, Cao J, Newman AH, Xi ZX. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine. Neuropharmacology 2019; 158: 107609.
7. Aronson JK. Meyler's side effects of drugs: the international encyclopedia of adverse drug reactions and interactions: Indian J Pharmacol 2016; 48(2): 224.
8. Dhawan A, Modak T, Sarkar S. Transdermal buprenorphine patch: potential for role in management of opioid dependence. Asian J Psychiatr 2019; 40: 88-91
9. Burke NN, Ferdousi M, Deaver DR, Finn DP, Roche M, Kelly JP. Locomotor and anti-immobility effects of buprenorphine in combination with the opioid receptor modulator samidorphan in rats. Neuropharm. 2019; 146: 327-36.
10. Haddadi M, Rahimi-Movaghar A, Farrahi F, Farahmandfar M. Comparison of the effects of methadone with buprenorphine on reproductive [sexual) hormone profile and seminal fluid analysis [fertility) in men on maintenance treatment. Clin Exc 2019; 9(1): 48-60 .[in Persian]
11. Khodabakhsh Nejad F, Moayer F, Khosravi Dehaghi N. Histopathological effect of buprenorphine administration on testis of rat. Pajoohandeh J 2016; 21(3): 130-7. [in Persian]
12. Gowing L, Ali R, White JM, Mbewe D. Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews 2017(2).
13. Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor R, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. NIHR Health Technology Assessment programme: Executive Summaries: NIHR J Library; 2007.
14. Mokri A. Methadone, Buprenorhine or Opium Tincture; Choosing the Right Agonist for Maintenance Treatment. J Addiction Med 2014; 1(4): 8-9. [in Persian]
15. Massah O. Male Sexual Disorders During Maintenance Therapy; a Comparison Between Methadone and Buprenorphine. Persian J Addiction Med 2015; 2(8): 46-8. [in Persian]
16. Gerra G, Manfredini M, Somaini L, Maremmani I, Leonardi C, Donnini C. Sexualdysfunction in men receiving methadonemaintenance treatment: clinical history and psychobiological correlates. Eur Addict Res 2016; 22(3): 163-75.
17. Bonakdaran S, Akbari Rad M, Hasanzadeh Deloie M, Akhoondpoor Manteghi M, Firoozi A. QTc prolongation in methadone users and its relation with hormonal changes. MUMS 2017; 60(2): 441-9.
18. Yee A, Loh HS, Ng CG. The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study. J Sexual Med 2014; 11(1): 22-32.
19. Safarinejad M. Sexual disorders in substance abusers who are treated with methadone.drsafarinejad.net/category/male-uro.
20. Salsitz,E.Eiegand T.pharmacotherapy of opioid addiction: putting a real face on a false Demon. J Med Toxicol 2016; 12(1): 58-68.
21. Yee A, Loh HS, Danaee M, Riahi S, Ng CG, Sulaiman AH. Plasma testosterone and sexual function in Southeast Asian men receiving methadone and buprenorphine maintenance treatment. J Sex Me 2018; 15(2): 159-66.
22. Ammozegar FS, Salehi M, Tarrahi MJ, Molaeinezhad M, Moradinasab F. The effect of maintenance treatment with methadone and buprenorphine on sexual function of females addicted to opiates. Iran J Obstet Gynecol Infertil 2021; 24(3): 23-32.
23. Hassanipour Azgomi S, Arab Zozani M, Maghsoudi A, Mokhtari AM, Ghadiri Rad R. Comparing sexual dysfunction in maintenance therapy with Methadone and Buprenorphine in married male. Int J Epidemiol Res 2016; 3(3): 55-65.
24. Quaglio G, Lugoboni F, Pattaro C. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug Alcohol Depend 2008; 94(5): 12-8.
25. Kheradmand A, Fazeli A, Meybodi AM. Comparing the effects of methadone, buprenorphine, and opium tincture maintenance therapy on sexual function. Addict Health 2019; 11(2): 120-44.
26. Besharat MA, HOSSEIN ZBR. A comparative study of fertile and infertile women’s mental health and sexual problems. IJPCP 2006; 12(2): 146-53. [in Persian]
27. Besharat MA, Hosseinzadeh Bazargani R, Mirzamani Bafghi M. Sexual problems of infertile couples. Res Behav Sci 2003; 1(2): 8-13.
28. Rust J, Bennun I, Crowe M. The Golombok Rust Inventory of Marital State (GRIMS): Test and handbook. Windsor, United Kingdom: NFER-Nelson. 1988.
29. Yee A, Danaee M, Loh HS, Sulaiman AH, Ng CG. Sexual dysfunction in heroin dependents: a comparison between methadone and buprenorphine maintenance treatment. PloS One 2016; 11(1): e0147852.
30. Tatari F, Farnia V, Faghiyeh Nasiri R, Najafi F. The effects of Trazodone on erectile function in patients on methadone maintenance treatment. Iran J Psychiatry 2010; 5: 164-6.
31. Hosseini SH, Isapour A, Tavakoli M, Taghipour M, Rasuli M. Erectile dysfunction in methadone maintenance patients: a cross sectional study in northern Iran. Iranian J Psychiatr 2013; 8(4): 172-99.
32. Ramdurg S, Ambekar A, Lal R. Sexual dysfunction among male patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence. J Sex Med 2012; 9(12): 3198-204.
33. Tafreshian S, Javadi M, Fakhraei F, Fatemi SS. Sexual dysfunction in male patients receiving methadone and buprenorphine maintenance treatment in Iran. Heroin Addict Rel Clin Probl 2014; 16(3): 49-54.
34. Wafaee Najjar A, Imamian H, Darabi Z, Kashfi T. Comparison of sexual satisfaction in addicts under maintenance treatment with methadone and buprenorphine. Graduate Students Conference; Mashhad. Mashhad University of Medical Sciences; 2013. [in Persian]
35. Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmuller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metabol 2005; 90(1): 203-6.
36. Bawor M, Bami H, Dennis BB, Plater C, Worster A, Varenbut M, et al. Testosterone suppression in opioid users: a systematic review and meta-analysis. Drug Alcohol Depend 2015; 149(5): 1-9.
37. Gladue BA, Clemens LG. Flutamide inhibits testosterone-induced masculine sexual behavior in male and female rats. Endocrinol 1980; 106(6): 1917-22.
38. Nimroozi R, Mastropietro D, Omidian H. Opioid abuse and deterrence: buprenorphine products. J Develop Drugs 2014; 3(117): 2-12.
39. Heidari Z, Mahmoudzadeh S, Kohan F. A quantitative and qualitative study of rat testis following administration of methadone and buprenorphine. Int J High Risk Behav Addict 2012; 1(1): 14-7.
40. Déglon JJ, Martin JL, Imer RL. Methadone patients’ sexual dysfunctions: Clinical and treatment issues. Heroin Add Rel Clin Probl 2004; 6(3): 17-26.
41. Shinderman MS, Maxwell S. Sexual dysfunction associated with methadone maintenance: Treatment with bromocryptine. Heroin Add Rel Clin Probl 2000; 2(1): 9-14.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ahmadvand A, Mansournejad M, Sepehrmanesh Z. Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021. Feyz 2023; 27 (1) :90-96
URL: http://feyz.kaums.ac.ir/article-1-4711-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 27, Issue 1 (Bimonthly 2023) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4645